In the second installment of our Johns Hopkins series, hosts Dr. Steven Taback and Bill Curtis are joined by Dr. Ken Pienta, Professor of Urology, Oncology, Pharmacology, Molecular Sciences, and Director or Research for The James Buchanan Brady Urological Institute as he sheds light on the state of the art for treatment and outcomes of prostate cancer.

In this dedicated series, we're showcasing the medical breakthroughs & innovations from one of the world's most preeminent hospitals: Johns Hopkins Medicine.

Johns Hopkins Medicine is dedicated to improving the health of the community and the world by setting the standard of excellence in medical education, research, and clinical care.

Timestamps:

1:46 What is it about Johns Hopkins that continues to produce top rankings and the gold standard for practice and research?

3:20 Does Johns Hopkins build their own robotics systems?

4:05 Why do so many of men still die from prostate cancer?

5:30 With prostate cancer numbers continually so high, why not prophylactically remove the prostate?

7:35 What are the signs men should look for the indicate prostate cancer?

8:37 What is the efficacy of the Prostate Specific Antigen (PSA) test, and what drawbacks does it have?

13:43 Is there a time to proceed with a biopsy without visible lesions from an MRI?

16:04 Proton Therapy and prostate cancer?

17:54 The use of radiation and hormone type therapy on younger men with prostate cancer

18:55 Incontinence and impotence post prostate treatment

20:30 Are there lifestyle changes one can make to prevent prostate cancer?

21:36 Immunotherapy and prostate cancer

22:54 What is the state of the art relative to testosterone and prostate cancer?

26:35 How depressed are the numbers for screening prostate cancer during the COVID pandemic, and what is the fallout to lack of testing?



-----------------

Learn More: Medicine, We’re Still Practicing

Follow Us: Twitter | Facebook | Instagram

Hosted by: Dr. Steven Taback & Bill Curtis

Produced and Edited by: AJ Moseley

Sound Engineering by: Steve Reickeberg

Theme Music by: Celleste and Eric Dick

A CurtCo Media Production

In the second installment of our Johns Hopkins series, hosts Dr. Steven Taback and Bill Curtis are joined by Dr. Ken Pienta, Professor of Urology, Oncology, Pharmacology, Molecular Sciences, and Director or Research for The James Buchanan Brady Urological Institute as he sheds light on the state of the art for treatment and outcomes of prostate cancer.
In this dedicated series, we're showcasing the medical breakthroughs &amp; innovations from one of the world's most preeminent hospitals: Johns Hopkins Medicine.
Johns Hopkins Medicine is dedicated to improving the health of the community and the world by setting the standard of excellence in medical education, research, and clinical care. Timestamps: 1:46 What is it about Johns Hopkins that continues to produce top rankings and the gold standard for practice and research? 3:20 Does Johns Hopkins build their own robotics systems? 4:05 Why do so many of men still die from prostate cancer? 5:30 With prostate cancer numbers continually so high, why not prophylactically remove the prostate? 7:35 What are the signs men should look for the indicate prostate cancer? 8:37 What is the efficacy of the Prostate Specific Antigen (PSA) test, and what drawbacks does it have? 13:43 Is there a time to proceed with a biopsy without visible lesions from an MRI? 16:04 Proton Therapy and prostate cancer? 17:54 The use of radiation and hormone type therapy on younger men with prostate cancer 18:55 Incontinence and impotence post prostate treatment 20:30 Are there lifestyle changes one can make to prevent prostate cancer? 21:36 Immunotherapy and prostate cancer 22:54 What is the state of the art relative to testosterone and prostate cancer? 26:35 How depressed are the numbers for screening prostate cancer during the COVID pandemic, and what is the fallout to lack of testing? 
-----------------
Learn More: <a href="https://www.curtco.com/stillpracticing">Medicine, We&rsquo;re Still Practicing</a>
Follow Us: <a href="https://www.twitter.com/medspodcast">Twitter </a>| <a href="https://www.facebook.com/curtcomedia">Facebook</a> | I<a href="https://www.instagram.com/curtcomedia">nstagram</a>
Hosted by: Dr. Steven Taback &amp; Bill Curtis
Produced and Edited by: AJ Moseley
Sound Engineering by: Steve Reickeberg
Theme Music by: <a href="https://www.curtco.com/music">Celleste and Eric Dick</a>
A <a href="https://www.curtco.com">CurtCo Media </a>Production

Hosted by Bill Curtis and quadruple board certified Dr. Steven Taback, Medicine, We’re Still Practicing sits down with doctors from the world’s most preeminent hospitals for insights into their research, practice, and education. The first in this dedicated series is Johns Hopkins Medicine, with the goal of not only to share the magnificent work being done by these hospitals and doctors, but for them to be able to use it as a high-quality educational tool and platform to share insights and research to a large, receptive audience. Medicine, We’re Still Practicing is a thoroughly informative and realistic podcast that speaks not only to the layman medical audience, but appeals to the medical community as well. 

No topic is off limits, from the insurance industry and universal healthcare to the latest medical advances and all of the quackery and snake oil salesmen you should avoid. However, in accordance with good bedside manner, Dr. Taback and his guests from the medical community keep the conversation light and informative. An important listen during these times of medical uncertainty and differed opinions.

Hosted by Bill Curtis and quadruple board certified Dr. Steven Taback, Medicine, We&rsquo;re Still Practicing sits down with doctors from the world&rsquo;s most preeminent hospitals for insights into their research, practice, and education. The first in this dedicated series is Johns Hopkins Medicine, with the goal of not only to share the magnificent work being done by these hospitals and doctors, but for them to be able to use it as a high-quality educational tool and platform to share insights and research to a large, receptive audience. <a href="https://www.curtco.com/stillpracticing">Medicine, We&rsquo;re Still Practicing</a> is a thoroughly informative and realistic podcast that speaks not only to the layman medical audience, but appeals to the medical community as well.&nbsp;
No topic is off limits, from the insurance industry and universal healthcare to the latest medical advances and all of the quackery and snake oil salesmen you should avoid. However, in accordance with good bedside manner, Dr. Taback and his guests from the medical community keep the conversation light and informative. An important listen during these times of medical uncertainty and differed opinions.

Medicine, We're Still Practicing

Dr. Ken Pienta, Professor of Urology, Oncology, Pharmacology, Molecular Sciences, and Director of Research for The James Buchanan Brady Urological Institute, shares his insight on the state-of-the-art treatment and outcomes for prostate cancer. From proton therapy to immunotherapy, Johns Hopkins is leading the way in innovative ways for the treatment of this widespread disease.

23 - Dr. Ken Pienta: Pinning Down Prostate Cancer (Johns Hopkins Series)

https://api.omny.fm/orgs/4fab3663-bc0e-42da-bca1-ab68000eb109/clips/46b18039-58c8-4987-9e50-accb01873c22/transcript

Advertisement